Interferons and the central nervous system glia

Interferon Therapy of Multiple Sclerosis

Volumn , Issue , 1997, Pages 95-114

  Vartanian, Timothy ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 7344245943     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (108)

1. Jacobson M. Developmental Neurobiology. 3rd ed. New York: Plenum, 1991.
2. Theele DP, Streit WJ. A chronicle of microglial ontogeny. Glia 1993; 7:5-8.
3. Kandel ER. Nerve cells and behavior. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science. 3rd ed. Norwalk, CT: Appleton & Lange, 1991.
4. Waxman SG, Ritchie JM, eds. Advances in Neurology. Vol. 31: Demyelinating Diseases: Basic and Clinical Electrophysiology. New York: Raven Press, 1981.
5. McMillian MK, Thai L, Hong J-S, O'Callaghan JP, Pennypacker KR. Brain injury in a dish: a model for reactive gliosis. TINS 1994; 17:138-142.
6. Ling E-A, Wong W-C. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 1993; 7:9-18.
7. Traugott U, Lebon P. Multiple sclerosis: Involvement of interferons in lesion pathogenesis. Ann Neurol 1988; 24:243-251.;
8. Rubio N, de Felipe C. Demonstration of the presence of a specific interferon- y receptor on murine astrocyte cell surface. J Neuroimmunol 1991; 35:111-117.
9. Yong VW, Moumdjian R, Yong FP, et al. y-Interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA 1991; 88:7016-7020.
10. Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Wee Yong V. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 1994; 14:846-856.
11. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J Immunol 1990; 144:129-135.
12. +exchange in astrocytes. J Biol Chem 1994; 19:13811-13816.
13. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 1993; 13:1441-1453.
14. Lee SC, Dickson DW, Liu W, Brosnan CF. Induction of nitric oxide synthase activity in human astrocytes by interleukin-10 and interferon-y. J Neuroimmunol 1993; 46:19-24.
15. Simmons ML, Murphy S. Roles for protein kinases in the induction of nitric oxide synthase in astrocytes. Glia 1994; 11:227-234.
16. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993; 13:2651-2661.
17. Muntiz-Fernandez MA, Fresno M. Involvement of nitric oxide on the cytokine induced growth of glial cell. Biochem Biophys Res Commun 1993; 194: 319-325.
18. Bolanos JP, Peuchen S, Heales JR, Land JM, Clark JB. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem 1994; 63:910-916.
19. Cannella B, Raine, CS. The adhesion molecule and cytokine profile of MS lesions. Ann Neurol 1995; 37:424-435.
20. Vartanian T, Li Y, Zhao M, Stefansson K. Interferon-y induced oligodendrocyte death: implications for the pathogenesis of MS. Mol Med (In press).
21. Schmidt B, Stoll G, Toyka KV, Hartung HP. Rat astrocytes express interferon- y immunoreactivity in normal optic nerve and after nerve transection. Brain Res 1990; 515:347-350.
22. Kiefer R, Kreutzberg GW. Gamma interferon-like immunoreactivity in the rat nervous system. Neuroscience 1990; 37:725-734.
23. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992; 263:C1-16.
24. Chung IY, Benveniste EN. Tumor necrosis factor-a production by astrocytes: induction by lipopolysaccharide, IFN-y, and IL-10. J Immunol 1990; 144:2999-3007.
25. Chung IY, Norris JG, Benveniste EN. Differential tumor necrosis factor α expression by astrocytes from experimental allergic encephalomyelitissusceptible and -resistant rat strains. J Exp Med 1991; 173:801-811.
26. Oropeza RL, Wekerle H, Werb Z. Expression of apolipoprotein E by mouse brain astrocytes and its modulation by interferon-y. Brain Res 1987; 410 45-51.
27. Low KG, Allen RG, Melner MH. Differential regulation of proenkephalin expression in astrocytes by cytokines. Endocrinology 1992; 131:1908-1914.
28. Tontsch U, Rott O. Intercellular regulation of major histocompatibility complex class I expression in neural cells. Immunology 1993; 80:507-509.
29. Frohman EM, Vayuvegula B, Gupta S, van den Noort S. Norepinephrine inhibits y interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via /32-adrenergic signal transduction mechanisms. Proc Natl Acad Sci USA 1988; 85:1292-1296.
30. Frohman EM, Vayuvegula B, van den Noort S, Gupta S. Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) intigen expression on cultured brain astrocytes. J Neuroimmunol 1988; 17:89-101.
31. Lee SC, Collins M, Vanguri P, Shin ML. Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J Immunol 1992; 148:3391-3397.
32. Male DK, Pryce G, Hughes CCW. Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared. Immunology 1987; 60:453-459.
33. Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW. Inducible expression of H-2 and Ia antigens on brain cells. Nature 1984; 310:688-691.
34. Tedeschi B, Barrett JN, Keane RW. Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J Cell Biol 1986; 102:2244-2253.
35. Uitdehaag BMJ, deGroot CJA, Kreike A, et al. The significance of insitu antigen expression in the pathogenesis of autoimmune central nervous system disease. J Autoimmun 1993; 6:323-335.
36. Traugott U, Scheinberg LC, Raine CS. On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol 1985; 8:1.
37. Hayes GM, Woodroofe MN, Cuzner ML. Microglia are the major cell type expressing MHC Class II antigens in human white matter. J Neurol Sci 1987; 80:25.
38. Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T cell lines. Nature 1984; 307:273.
39. Dhib-Jalbut S, Kufta CV, Flerlage M, Shimojo N, McFarland HF. Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells. J Neuroimmunol 1990; 29:203-211.
40. Fontana A, Erb P, Pircher H, et al. Astrocytes as antigen-presenting cells. Part II: Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-y. J Neuroimmunol 1986; 12:15-28.
41. Takiguchi M, Frelinger JA. Induction of antigen presentation ability in puri fied cultures of astroglia by interferon-y. J Mol Cell Immunol 1986; 2: 269-280.
42. Sedgwick JD, Mobner R, Schwender S, ter Meulen V. Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+T lymphocytes: Astroglial cells as perpetuators but not initiators of CD4± T cells responses in the central nervous system. J Exp Med 1991; 173:1235-1246.
43. Reder AT, Lascola CD, Flanders SA, Maimone D, Jensen MA, Skias DD, Lancki DW. Astrocyte cytolysis by MHC class II-specific mouse T cell clones. Transplantation 1993; 56:393-399.
44. Massa PT, ver Meulen V, Fontana A. Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis (EAE). Proc Natl Acad Sci USA 1987; 84: 4219.
45. Borrow P, Nash AA. Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation. Immunology 1992; 76:133-139.
46. Johns LD, Babcock G, Green D, et al. Transforming growth factor-/31 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem strocyte primary cultures. Brain Res 1992; 585: 229-236.
47. Wilkin GP, Marriot DR, Cholewinski AJ. Astrocyte heterogeneity. Trends Neurol Sci 1990; 2:43-45.
48. Lassmann H, Schmeid M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993; 7:19-24.
49. Kettenmann H, Banati R, Walz W. Electrophysiological behavior of microglia. Glia 1993; 7:93-101.
50. Lumsden CE, in Handbook of Clinical Neurology: The Neuropathology of Multiple Sclerosis 9, 217-309 (Elsevier Science, Amsterdam, 1985).
51. Guilian D, Vaca K, Johnson B. Secreted peptides as regulators of neuronglia and glia-glia interactions in the developing nervous system. J Neurosci Res 1988; 21:487-500.
52. Guilian D, Vaca K, Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 1993; 13:29-37.
53. Guilian D. Reactive glia as rivals in regulating neuronal survival. Glia 1993; 7:102-110.
54. Suzumura A, Marunouchi T, Yamamoto H. Morphological transformation of microglia in vitro. Brain Res 1991; 545:301-306.
55. Colton CA, Yao J, Keri JE, Gilbert D. Regulation of microglial function by interferons. J Neuroimmunol 1992; 30:89-98.
56. Bruck W, Friede RL. Activation of macrophages by recombinant interferon- y has no effect on myelin phagocytosis but hinders invasion of nerves in organ culture. J Neuroimmunology. 1989; 25:47-55.
57. Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL. Expression of MRP14, 27E10, interferon-y and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J Neuroimmunol 1994; 50: 195-201.;
58. Neveu I, Naveilhan P, Menaa C, Wion D, Brachet P, Garabedian M. Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J Neurosci Res 1994; 38:214-220.
59. Corradin SB, Mauel J, Donini SD, Quattrocchi E, Ricciardi-Castagnoli P. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 1993; 7:255-262.
60. Zielasek J, Tausch M, Toyka KV, Hartung H-P. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell Immunol 1992; 141: 111-120.
61. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992; 149:2736-2741.
62. Peterson PK, Hu S, Anderson R, Chao CC. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis 1994; 170:457-460.
63. Lee SC, Dickson DW, Liu W, Brosnan CF. Induction of nitric oxide synthase activity in human astrocytes by interleukin-l/3 and interferon-y. J Neuroimmunol 1993; 46:19-24.
64. Dawson TM, et al. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 1988; 88:7797-7801.
65. Hope BT, et al. Neuronal NADPH-diaphorase is a nitric oxide synthase. Proc Natl Acad Sci 1988; 88:2811-2814.
66. Chao CC, Gekker G, Hu S, Peterson PK. Human microglial cell defense against toxoplasma gondii; the role of cytokines. J Immunol 1994; 152: 1246-1252.
67. Chao CC, Anderson WR, Hu S, et al. Activated microglia inhibit multiplication of toxoplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol 1993; 67:178-183.
68. Jun C-D, Ryu H, Um J-Y, et al. Involvement of protein kinase C in the inhibition of nitric oxide production from murine microglial cells by glucocorticoid. Biochem Biophys Res Commun 1994; 199:633-638.
69. Suzumura A, Mezitis SGE, Gonatas NK, Silberberg DH. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by y-interferon. J Neuroimmunol 1987; 15:263-278.
70. Steiniger B, van der Meide PH. Rat ependyma and microglia cells express class II MHC antigens after intravenous infusion of recombinant gamma interferon. J Neuroimmunol 1988; 19:111-118.
71. Woodroofe MN, Hayes GM, Cuzner ML. Fc receptor density, MHC antigen expression and superoxide production are increased in interferongamma— treaed microglia isolated from adult rat brain. Immunology 1989; 68:421-426.
72. Loughlin AJ, Woodroofe MN, Cuzner ML. Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rat mi roglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: effects on interferon-gamma induced activation. Immunology 1992; 75: 170-175.
73. Frei K, Siepl C, Groscurth P, et al. Antigen presentation and tumor cytotoxicity by interferon-y—treated microglial cells. Eur J Immunol 1987; 17: 1271-1278.
74. Loughlin AJ, Woodroofe MN, Cuzner ML. Modulation of interferon-y—induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-01, interleukin-4, noradrenaline and glucocorticoids. Immunology 1993; 79:125-130.
75. Hayashi M, Dorf ME, Abromson-Leeman A. Granulocyte-macrophage colony stimulating factor inhibits class II major histocompatibility complex expression and antigen presentation by microglia. J Neuroimmunol 1993; 48:23-32.
76. Cash E, Rott O. Microglial cells qualify as the stimulators of unprimed CD4± and CD8± T lymphocytes in the central nervous system. Clin Exp Immunol 1994; 98:313-318.
77. Williams Jr. K, Ulvestad E, Cragg L, Blain M, Antel JP. Induction of primary T cell responses by human glial cells. J Neurosci Res 1993; 36: 382-390.
78. Griffin WST, Stanley LC, Ling C, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86:7611-7615.
79. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J Immunol 1991; 147:1522-1529.
80. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23:339-346.
81. Louis J-C, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor—induced death. Science 1993; 259:689-692
82. Suzumura A, Silberberg DH, Lisak RP. The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphocytes. J Neuroimmunol 1986; 11:179-190.
83. Hirayama M, Yokochi T, Shimokata K, Iida M, Fujiki N. Induction of human leukocyte antigen-A, B, C and -DR on cultured human oligodendrocytes and astrocytes by human y-interferon. Neurosci Lett 1986; 72: 369-374.
84. Bergsteinsdottir K, Brennan A, Jessen KR, Mirsky R. In the presence of dexamethasone, y interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 1992; 89:9054-9058.
85. Massa PT, Ozato K, McFarlin DE. Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 1993; 8:201-207.
86. Calder VL, Wolswijk G, Noble M. The differentiation of O-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility if Ia antigens. Eur J Immunol 1988; 18:1195-1201.
87. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 is a ligand for lymphocyte function-associated antigen 1. Cell 1987; 51:813-819.
88. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988; 52:925-933.
89. Satoh J-K, Kastrukoff LF, Kim SU. Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J Neuropathol Exp Neurol 1991; 50:215-226.
90. Soliven B, Szuchet S, Nelson DJ. Tumor necrosis factor inhibits K± current expression in cultured oligodendrocytes. J Membrane Biol 1991; 124: 127-137.
91. Soliven B, Szuchet S. Signal Transduction pathways in oligodendrocytes: Role of tumor necrosis factor-a. Int J Dev Neurosci 1995; 13:351-367.
92. Mauerhoff T, Pujol-Borrell R, Mirakian R, Bottazzo GF. Differential expression and regulation of major histocompatibility complex (MHC) products in neural and glial cells of the human fetal brain. J Neuroimmunol 1988; 18:271-289.
93. Merrill JE. The effect of IL-1 and TNFa on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev Neurosci 1991; 13:130.
94. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 151:2132-2141.
95. Prineas JW, Kwon EE, Goldenberg PZ, Cho E-S, Sharer LR. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab Invest 1990; 63:624-636.
96. Sun D. Enhanced interferon-y-induced Ia-antigen expression by glial cells after previous exposure to this cytokine. J Neuroimmunol 1991; 34:205-214.
97. Abu El-Asrar AM, Maimone D, Morse PH, Lascola C, Reder AT. Interferon- y and tumour necrosis factor induce expression of major histocompatibility complex antigen on rat retinal astrocytes. Br J Opthalmol 1991; 75: 473-475.
98. Fierz W, Endler B, Reske K, Wekerle H, Fontana A. Astrocytes as antigenpresenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 1985; 134:3785-3793.
99. Benveniste EN, Sparacio SM, Bethea JR. Tumor necrosis factor-a enhances interferon- y-mediated class II antigen expression on astrocytes. J Neuroimmunol 1989; 25:209-219.
100. Smith ME, McFarlin DE, Dhib-Jalbut S. Differential effect of interleukinlp on Ia expression in astrocytes and microglia. J Neuroimmunol 1993; 46: 97-104.
101. Ohira K, Vayuvegula B, Murakami M, et al. Tetraethylammonium, a K channel blocker, inhibits interferon-y-induced major histocompatibility lass II antigen (Ia) expression and DNA synthesis in rat astrocytes. J Neuroimmunol 1991; 31:43-49.
102. Frohman EM, Frohman TC, Dustin ML, et al. The induction of intercellular adhesion molecule 1 (ICAM-l) expression on human fetal astrocytes by interferon-y, tumor necrosis factor a, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J Neuroimmunol 1989; 23: 117-124.
103. Sasaki A, Levison SW, Ting JPY. Differentiatial suppression of interferony— induced Ia antigen expression on cultured rat astroglia and microglia by second messengers. J Neuroimmunol 1990; 29:213-222.
104. Schluesener HJ. Transforming growth factors type 0, and 02 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-y and tumor necrosis factor-a. J Neuroimmunol 1990; 27:41-47.
105. Yong VW, Yong FP, Ruus TCG, Antel JP, Kim SU. Expression and modulation of HLA-DR on cultured human adult astrocytes. J Neuropathol Exp Neurol 1991; 50:16-28.
106. Pulver M, Carrel S, Mach JP, de Tribolet N. Cultured human fetal astrocytes can be induced by interferon-y to express HLA-DR. J Neuroimmunol 1987; 14:123-133.
107. Morris AG, Tomkins PT. Interactions of interferons in the induction of histocompatibility antigens in mouse fibroblasts and glial cells. Immunology 1989; 67:537-539.
108. Haegel H, Tolg C, Hofmann M, Ceredig R. Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocytes T cell binding. J Cell Biol 1993; 122:1067-1077.;